TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/24 21:47 | 3/11/24 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sandison Taylor | CA | O | Chief Me | S | -14 | 0.6698 | 0 | -21 | -6 | 347 | D | ||||||||||||||
9/13/23 16:22 | 9/11/23 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sandison Taylor | CA | O | Chief Me | S | -18 | 0.9477 | 0 | -19 | -5 | 364 | D | ||||||||||||||
3/13/23 21:19 | 3/13/23 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sandison Taylor | CA | O | Chief Me | S | -11 | 1.53 | 0 | -7 | -2 | 289 | D | ||||||||||||||
9/13/22 18:51 | 9/12/22 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sandison Taylor | CA | O | Chief Me | S | -13 | 0.6849 | 0 | -18 | -6 | 292 | D | ||||||||||||||
1/7/22 20:22 | 12/29/21 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sandison Taylor | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 16 | 6 | 256 | D | ||||||||||||||
6/8/17 16:40 | 6/6/17 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sandison Taylor | CA | O | Chief Me | P.m | 118 | 5.90 | 0 | 20 | 351 | 26 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |